Theresa Heggie - Net Worth and Insider Trading
Theresa Heggie Net Worth
The estimated net worth of Theresa Heggie is at least $413,303 dollars as of 2024-11-13. Theresa Heggie is the Director of BioCryst Pharmaceuticals Inc and owns about 52,852 shares of BioCryst Pharmaceuticals Inc (BCRX) stock worth over $413,303. Details can be seen in Theresa Heggie's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Theresa Heggie has not made any transactions after 2024-06-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Theresa Heggie
Theresa Heggie Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Theresa Heggie owns 1 companies in total, including BioCryst Pharmaceuticals Inc (BCRX) .
Click here to see the complete history of Theresa Heggie’s form 4 insider trades.
Insider Ownership Summary of Theresa Heggie
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2024-06-14 | director |
Theresa Heggie Latest Holdings Summary
Theresa Heggie currently owns a total of 1 stock. Theresa Heggie owns 52,852 shares of BioCryst Pharmaceuticals Inc (BCRX) as of June 14, 2024, with a value of $413,303.
Latest Holdings of Theresa Heggie
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BCRX | BioCryst Pharmaceuticals Inc | 2024-06-14 | 52,852 | 7.82 | 413,303 |
Holding Weightings of Theresa Heggie
Theresa Heggie Form 4 Trading Tracker
According to the SEC Form 4 filings, Theresa Heggie has made a total of 2 transactions in BioCryst Pharmaceuticals Inc (BCRX) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in BioCryst Pharmaceuticals Inc is the sale of 6,698 shares on June 14, 2024, which brought Theresa Heggie around $40,925.
Insider Trading History of Theresa Heggie
- 1
Theresa Heggie Trading Performance
GuruFocus tracks the stock performance after each of Theresa Heggie's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Theresa Heggie is 72.06%. GuruFocus also compares Theresa Heggie's trading performance to market benchmark return within the same time period. The performance of stocks bought by Theresa Heggie within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Theresa Heggie's insider trading performs compared to the benchmark.
Performance of Theresa Heggie
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 85.88 | | | | | |
| Relative Return to S&P 500(%) | 83.67 | | | | | |
Theresa Heggie Ownership Network
Ownership Network List of Theresa Heggie
Ownership Network Relation of Theresa Heggie
Theresa Heggie Owned Company Details
What does BioCryst Pharmaceuticals Inc do?
Who are the key executives at BioCryst Pharmaceuticals Inc?
Theresa Heggie is the director of BioCryst Pharmaceuticals Inc. Other key executives at BioCryst Pharmaceuticals Inc include Chief Financial Officer Anthony Doyle , Vice President and CCO Charles K Gayer , and VP & General Counsel & Corp Sec Alane P Barnes .
BioCryst Pharmaceuticals Inc (BCRX) Insider Trades Summary
Over the past 18 months, Theresa Heggie made no insider transaction in BioCryst Pharmaceuticals Inc (BCRX). Other recent insider transactions involving BioCryst Pharmaceuticals Inc (BCRX) include a net sale of 8,689 shares made by Machelle Sanders , a net sale of 7,866 shares made by Nancy J Hutson , and a net purchase of 36,300 shares made by Anthony Doyle .
In summary, during the past 3 months, insiders sold 0 shares of BioCryst Pharmaceuticals Inc (BCRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 36,853 shares of BioCryst Pharmaceuticals Inc (BCRX) were sold and 183,601 shares were bought by its insiders, resulting in a net purchase of 146,748 shares.
BioCryst Pharmaceuticals Inc (BCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioCryst Pharmaceuticals Inc Insider Transactions
Theresa Heggie Mailing Address
Above is the net worth, insider trading, and ownership report for Theresa Heggie. You might contact Theresa Heggie via mailing address: 4505 Emperor Boulevard, Suite 200, Durham Nc 27703.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
